Zalicus Inc. (ZLCS) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 61 transactions totaling $34.8M, demonstrating a bearish sentiment with -$34.8M in net insider flow. The most recent transaction on Feb 10, 2014 involved a transaction of 250,000 shares valued at $0.
No significant insider buying has been recorded for ZLCS in the recent period.
No significant insider selling has been recorded for ZLCS in the recent period.
Based on recent SEC filings, insider sentiment for ZLCS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$34.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Zalicus Inc. (ZLCS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading ZLCS stock, having executed 61 transactions in the past 90 days. The most active insider is Bioventures III Gp L.p. Mpm (Executive), who has made 6 transactions totaling $14.0M.
Get notified when executives and directors at ZLCS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 10, 2014 | Corrigan Mark | Executive | Award | 250,000 | $N/A | $0 | |
| Feb 10, 2014 | A. Renz Justin | Executive | Award | 250,000 | $N/A | $0 | |
| Jan 15, 2014 | Corrigan Mark | Executive | Payment | 18,079 | $1.66 | $30.0K | |
| Jan 3, 2014 | Corrigan Mark | Executive | Payment | 8,035 | $1.22 | $9.8K | |
| Jan 15, 2013 | Corrigan Mark | Executive | Sale | 112,850 | $0.77 | $86.9K | |
| Jan 3, 2013 | Corrigan Mark | Executive | Award | 250,000 | $N/A | $0 | |
| Feb 29, 2012 | C. Gallen Christopher | Executive | Award | 350,000 | $N/A | $0 | |
| Jan 27, 2012 | Cole Jason | Executive | Sale | 2,420 | $1.09 | $2.6K | |
| Jan 17, 2012 | Corrigan Mark | Executive | Sale | 68,105 | $1.14 | $77.6K | |
| Oct 27, 2011 | Iii-qp L.p. Mpm Bioventures | Executive | Sale | 738,807 | $1.03 | $761.0K | Large |
| Oct 27, 2011 | Wheeler Kurt | Executive | Sale | 738,807 | $1.03 | $761.0K | Large |
| Oct 26, 2011 | III Llc Mpm Bioventures | Executive | Sale | 78,000 | $1.02 | $79.6K | |
| Oct 26, 2011 | Henner Dennis | Executive | Sale | 78,000 | $1.02 | $79.6K | |
| Oct 25, 2011 | III Llc Mpm Bioventures | Executive | Sale | 203,200 | $1.02 | $207.3K | |
| Oct 25, 2011 | Henner Dennis | Executive | Sale | 203,200 | $1.02 | $207.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 51 | $34.8M | 99.2% |
Exercise(M) | 4 | $255.7K | 0.7% |
Payment(F) | 2 | $39.8K | 0.1% |
Award(A) | 4 | $0 | 0.0% |
Insider selling pressure at Zalicus Inc. has increased, with 17 insiders executing 61 transactions across all time. Total sales of $34.8M significantly outpace purchases of $0, resulting in a net outflow of $34.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.